Skip to contentA
Acadia Healthcare Company, Inc.
A
ACHCAcadia Healthcare Company, Inc. Q2 2022 · 10-Q
Revenue$651.72M$651.72M+11.9% vs Q2 2021 Net Income$80.08M$80.08M+79.9% vs Q2 2021 EPS Diluted$0.88$0.88+79.6% vs Q2 2021 Operating Cash Flowderived$149,202,000+64.9% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acadia Healthcare Company, Inc. · CIK 1520697 · Engraved from SEC EDGAR
Free Cash Flowderived$67,285,000+85.8% Margins · derivedNet margin12.3%+4.6 pt vs Q2 2021
ended Jun 30, 2022 · filed Jul 28, 2022 · 28 d after period end